adenosine monophosphate has been researched along with digoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brooker, G; Thomas, LJ | 1 |
| DeNofrio, D; Holmes, EW; Loh, E; Mahoney, PD; Rebbeck, TR; Swain, JL | 1 |
| Cho, J; Choi, BS; Choi, JH; Kim, JH; Kim, SI; Kim, SS; Lee, YJ | 1 |
3 other study(ies) available for adenosine monophosphate and digoxin
| Article | Year |
|---|---|
Phosphatase and ouabain-sensitive adenosine triphosphatase activities of the perfused frog heart.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Anura; Digoxin; Epinephrine; Heart; Heart Ventricles; Hydrolysis; In Vitro Techniques; Kinetics; Muscle Contraction; Myocardium; Nitrobenzenes; Ouabain; Perfusion; Phosphoric Acids; Phosphoric Monoester Hydrolases; Phosphorus Isotopes; Rana pipiens; Spectrophotometry; Tritium | 1971 |
Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Topics: Adenosine Monophosphate; Aged; Alleles; AMP Deaminase; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Coronary Disease; Digoxin; Disease Progression; Diuretics; DNA Mutational Analysis; Energy Metabolism; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Phenotype; Proportional Hazards Models; Survival Analysis; Treatment Outcome | 1999 |
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Digoxin; Inhibitory Concentration 50; Ouabain; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |